Lin, Yan-Duo’s team published research in Energy Technology (Weinheim, Germany) in 2019 | CAS: 589-87-7

1-Bromo-4-iodobenzene(cas: 589-87-7) is mainly used as the OLED pharmaceutical intermediate, as reagent for in situ desilylation and coupling of silylated alkynes, as substrate in copper-free Sonogashira coupling in aqueous acetone..Quality Control of 1-Bromo-4-iodobenzene It is also used in synthesis of β,β,dibromostyrenes, as starting reagent in the total syntheses of ent-conduramine A and ent-7-deoxypancratistatin (alkaloids)

The author of 《Rational design of cyclopenta[2,1-b;3,4-b’]dithiophene-bridged hole transporting materials for highly efficient and stable perovskite solar cells》 were Lin, Yan-Duo; Lee, Kun-Mu; Ke, Bo-Yu; Chen, Kai-Shiang; Cheng, Hao-Chien; Lin, Wei-Juih; Chang, Sheng Hsiung; Wu, Chun-Guey; Kuo, Ming-Chung; Chung, Hsin-Cheng; Chou, Chien-Chun; Chen, Heng-Yu; Liau, Kang-Ling; Chow, Tahsin J.; Sun, Shih-Sheng. And the article was published in Energy Technology (Weinheim, Germany) in 2019. Quality Control of 1-Bromo-4-iodobenzene The author mentioned the following in the article:

A series of small-mol.-based hole-transporting materials (HTMs) featuring a 4H-cyclopenta[2,1-b : 3,4-b]dithiophene as the central core with triphenylamine- and carbazole-based side groups was synthesized and evaluated for perovskite solar cells. The correlations of the chem. structure of the HTMs on the photovoltaic performance were explored through different combinations of the central π-bridge moieties. The optical and electrochem. properties, energy levels, and hole mobility were systematically investigated, revealing the significant influence of the central core planarity and packing structure on their photovoltaic performance. The optimized device based on CT1 exhibited a PCE (power conversion efficiency) of 17.71% with a device architecture of FTO/TiO2 compact layer/TiO2 mesoporous/CH3NH3PbI3/HTM/MoO3/Ag, which was found to be on par with that of a cell fabricated based on state-of-the-art spiro-OMeTAD (16.97%) as HTM. Moreover, stability assessment showed an improved stability for CPDT-based HTMs in comparison with spiro-OMeTAD over 1300 h. In the experiment, the researchers used many compounds, for example, 1-Bromo-4-iodobenzene(cas: 589-87-7Quality Control of 1-Bromo-4-iodobenzene)

1-Bromo-4-iodobenzene(cas: 589-87-7) is mainly used as the OLED pharmaceutical intermediate, as reagent for in situ desilylation and coupling of silylated alkynes, as substrate in copper-free Sonogashira coupling in aqueous acetone..Quality Control of 1-Bromo-4-iodobenzene It is also used in synthesis of β,β,dibromostyrenes, as starting reagent in the total syntheses of ent-conduramine A and ent-7-deoxypancratistatin (alkaloids)

Referemce:
Iodide – Wikipedia,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com